VeriSeq PGS
A fully validated next-generation sequencing solution that provides accurate chromosome screening for selection of embryos most likely to be euploid.Read More...
Illumina has partnered with Vitrolife to sell our preimplantation genetic screening (PGS) and preimplantation genetic diagnosis (PGD) products in Europe, the Middle East, Africa, and the Americas. Vitrolife began taking customer orders in December of 2018 and transitioning all sales and support in early 2019. Both Illumina and Vitrolife are committed to ensuring a seamless transition.
The VeriSeq PGS Kit takes advantage of next-generation sequencing (NGS) technology to provide comprehensive, accurate screening of all 24 chromosomes for selection of embryos most likely to be euploid. Preimplantation genetic screening (PGS) results generated using VeriSeq PGS are comparable to those achieved with the widely used array-based 24sure technology. In addition, NGS offers the opportunity for improved assay workflow, higher throughput, and enhanced performance.1
NGS offers a highly sensitive method for screening embryos, requiring as little as 1 ng of DNA from a SurePlex DNA amplification reaction. DNA can be obtained from a blastomere biopsy, from a day 3 embryo, or from a trophectodermal (TE) biopsy from a blastocyst.
*Data calculations on file. Illumina, Inc., 2015.
The pregnancy rate shown for embryos analyzed using preimplantation genetic screening and morphology is 69.1%, much higher than the 41.7% achieved using morphology screening alone.2 Pilot study of young, good prognosis patients (age < 35, first-time IVF, no history of prior miscarriage, n = 103).
Using the VeriSeq PGS Kit - MiSeq in Low-Throughput Mode
Application Note | PDF< 1 MB
VeriSeq PGS Kit - MiSeq System Product Information Sheet
Product Information Sheet | PDF< 1 MB
BlueFuse Multi Analysis Software for Preimplantation Genetic Screening
Data Sheet | PDF< 1 MB
Illumina VariantStudio Data Analysis Software
Data Sheet | PDF2 MB
BlueFuse Multi Analysis Software for Molecular Cytogenetics
Data Sheet | PDF< 1 MB
BlueFuse Multi Analysis Software for Preimplantation Genetic Diagnosis
Data Sheet | PDF1 MB
VeriSeq NIPT Analysis Software (16 Samples)
Data Sheet | PDF< 1 MB
VeriSeq PGS Technical Guide to Aneuploidy Calling Documentation
SurePlex Summary Protocol Reference Guide Documentation
VeriSeq PGS Library Prep Kit Support Documentation
BlueFuse Workflow Manager User Guide (1000000028842) Documentation
BlueFuse Workflow Manager Quick Reference Card (15056206) Documentation
Custom Protocol Selector
Generates customized, end-to-end instructions
The 24sure Microarray has been discontinued. VeriSeq PGS provides an alternative solution for this application. Illumina remains committed to providing you with high-quality support and service.
A fully validated next-generation sequencing solution that provides accurate chromosome screening for selection of embryos most likely to be euploid.
Prepare sequencing libraries for small genomes, PCR amplicons, plasmids, or cDNA in as little as 90 minutes, with a low DNA input requirement.
Used to generate a DNA template from single cells. Ideal for use with VeriSeq PGS applications.
Optimized chemistry to increase cluster density and read length, and improve sequencing quality scores, compared to earlier MiSeq reagent kit versions.